Glycostem is invited to participate in the investor conference Stifel Midwest One-on-One Growth Conference on 12th November, 2020. This is a virtual 1 to 1 meeting and our CEO Troels Jordansen presents.
Glycostem attends the 2nd Annual Cell & Gene Therapy Manufacturing conference virtually. Our CEO Troels Jordansen shares Glycostem world’s first off-the-shelf NK cell-based immunotherapy in the fight against cancer.
Glycostem participates the 7th Solebury Trout Private Company Showcase co-hosted by BMO and Davis Polk. Glycostem CEO Troels Jordansen presents virtually on Thursday 15th Oct 2020, with featured presentation and Q&A session.
Glycostem CEO Troels Jordansen shares updates from Glycostem at Alliance for Regenerative Medicine’s 2020 Cell & Gene Virtual Meeting on the Mesa.
On 8th October 2020, Glycostem participates 2020 ISPE Biotechnology Virtual Conference. Glycostem CDO Volker Huppert presents our GMP manufacturing method of an off-the-shelf cell therapy product.
Glycostem participates the CBIIC (China BioMed Innovation and Investment Conference) virtual roadshow on 21st Sep 2020. Our CEO Troels Jordansen talks about the our company, pipelines and the forward-looking prospects of Glycostem.